# evidence from https://www.govinfo.gov/app/details/CFR-2025-title49-vol1

evidence from https://www.govinfo.gov/app/details/CFR-2025-title49-vol1 is an evidence.

IRI: <https://ontology.bommaritollc.com/id/01a0ee02-5bd3-7018-9d2c-3fd584be0be0>

Type: [prov:Entity](http://www.w3.org/ns/prov#Entity), [evidence](https://ontology.bommaritollc.com/vocab/core/Evidence)

- `dcterms:identifier`: 49 CFR 40.177
- `dcterms:source`: [https://www.govinfo.gov/app/details/CFR-2025-title49-vol1](https://www.govinfo.gov/app/details/CFR-2025-title49-vol1)
- **observation** (`bccore:observation`): 638ce4a4388a0cee
- **payload SHA-256** (`bccore:payloadSha256`): 40371fbfae04d3fc898c63731a2625af9a08e664f76b0c738d10a0f1bbf0eca0
- `prov:wasGeneratedBy`: [import.cfr](https://ontology.bommaritollc.com/activity/01a0ee01-f91f-7756-a6cc-e910609ed0a3)

## Pointing here

- Its wasDerivedFrom, from (2; `prov:wasDerivedFrom`):
  - [49 CFR 40.177 What does the second laboratory do with the split specimen when it is tested to reconfirm the presence of a drug or drug metabolite?](https://ontology.bommaritollc.com/id/01a0ee02-5bd3-7018-9d2c-3fd63fdbb0f5)
  - [cfr-section 49 CFR 40.177](https://ontology.bommaritollc.com/id/01a0ee02-5bd4-752d-b70d-0721932bd884)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0ee02-5bd3-7018-9d2c-3fd584be0be0.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0ee02-5bd3-7018-9d2c-3fd584be0be0.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0ee02-5bd3-7018-9d2c-3fd584be0be0.nt), [HTML](https://ontology.bommaritollc.com/id/01a0ee02-5bd3-7018-9d2c-3fd584be0be0)
Cite as: evidence from https://www.govinfo.gov/app/details/CFR-2025-title49-vol1. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0ee02-5bd3-7018-9d2c-3fd584be0be0
Release 0.1.0-rc38, graph hash 05350a11cf9d0c42fba51e92b877115781ab65cb92afcd6b172ff9f8f4abf0bd.
